Intellipharmaceutics, Inc (IPCI) Covered Calls

Intellipharmaceutics, Inc covered calls IntelliPharmaCeutics International, Inc., business activities include research, development, and commercialization of controlled-release and targeted pharmaceutical products.

There are no covered calls available for Intellipharmaceutics, Inc.

Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Intellipharmaceutics International, Inc. is a pharmaceutical company, which specializes in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded on October 22, 2009 and is headquartered in Toronto, Canada.